I’ve been thinking about how my time managing an IVF clinic has shaped my instincts as an angel investor. It’s a fascinating overlap — the precision and unpredictability of both fields. Last week, while discussing an IVF case with a patient, I realized how much this experience sharpens my approach to investing. In both domains, you’re dealing with the delicate balance of science and human emotion, the known and the unknown.
In the world of IVF, every patient represents a unique case, much like every startup I consider investing in. There’s a common misconception that success in IVF is a straightforward equation — a simple matter of science. Similarly, many believe that angel investing is about picking the right sector or founder. But here’s the reality: both are far more complex and nuanced than they appear on the surface.
In my practice, I’ve seen how the smallest variables can significantly affect outcomes. You could have the most advanced technology and the best team, but without understanding the subtleties of each case, you’re flying blind. The same applies to startups. Founders often focus on their product or idea, but it’s the unglamorous details — the team’s chemistry, the market’s quirks, the financial discipline — that determine success or failure.
In IVF, it’s not simply about performing a procedure; it’s about understanding the patient’s journey, their history, and tailoring the approach to fit their unique circumstances. This patient-centered approach has taught me to look beyond the surface when evaluating a startup. I remember a founder who had a brilliant idea but seemed too focused on the endgame — the exit strategy — rather than the journey of building a sustainable business. In my experience, this kind of short-sightedness can spell disaster.
Both IVF and investing involve managing risk and expectations. Patients often come with high hopes, fueled by stories of miraculous successes. Likewise, founders and investors can be swayed by tales of startups that became unicorns overnight. But the truth is, both IVF and startups are rife with uncertainty. Success is rarely guaranteed, and setbacks are part of the journey. As an investor, I’ve learned to be wary of the “sure thing.” If there’s one thing IVF has taught me, it’s that promises of certainty are often misleading. My experience with patients who have faced the harsh realities of fertility treatments has made me a more discerning investor, one who values transparency and honesty over hype.
Another lesson from IVF that I bring into my investing practice is the importance of resilience. The patients who persevere through failed cycles and try again teach a powerful lesson about determination. In the startup world, the ability to adapt, learn, and push forward after setbacks is invaluable. I’ve seen founders crumble at the first sign of trouble, and I’ve also seen those who take failure in stride, using it as a stepping stone to success.
One of the most profound parallels is the emotional investment involved in both fields. In IVF, you’re not just dealing with science; you’re dealing with hopes, dreams, and sometimes, heartbreak. As an investor, I find that the most rewarding partnerships are those where I’m not just backing a business, but also believing in a vision and a team. It’s about more than just money; it’s about being part of a journey that is deeply personal and transformative.
The skills I’ve honed in the clinic — listening, empathy, rigorous analysis — are the same ones I apply when evaluating a potential investment. Just as I would never promise a patient a guaranteed outcome, I approach each startup with a healthy dose of skepticism and curiosity. I dive deep, ask the difficult questions, and try to understand the full picture before making a decision.
I’ve seen many investors get caught up in the excitement of the next big thing, much like patients who are drawn to clinics promising miracle results. But I’ve learned to take a step back, to assess the fundamentals, and to trust my instincts. It’s about finding that balance between optimism and realism, between vision and execution.
So, if there’s one takeaway from my experience in both domains, it’s this: the real magic happens in the intersection of science and humanity, of data and emotion. Whether it’s creating life in a lab or nurturing a startup from the ground up, success is about understanding the bigger picture and the small details that make all the difference.
In the end, my dual roles as an IVF specialist and an angel investor boil down to one core principle: investing in people. Whether it’s a patient hoping for a child or a founder with a dream, it’s the human element that drives me. And that, I believe, is the secret to making a meaningful impact in both worlds.
For those of you navigating similar paths, whether in healthcare or investing, I encourage you to embrace the complexity, to look beyond the obvious, and to invest not just in ideas or outcomes, but in the people who make them possible. It’s a journey that’s as rewarding as it is challenging, and one that continually reaffirms my belief in the power of human endeavor.